Utama › Sistem Imun dan Gangguan › Florida
Kajian klinikal Sistem Imun dan Gangguan di Florida
11 kajian untuk Sistem Imun dan Gangguan sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Moffit Cancer Center, Tampa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07192471A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
Mengambil pesertaFasa 2
Umur 18 hingga 60 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07541287Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Holy Cross Hospital, Fort Lauderdale
- Mayo Clinic in Florida, Jacksonville
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04242095PS-002 for the Treatment of IgA Nephropathy in Adults
- University of Miami Hospital, Miami
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07182227A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07765888A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07075185Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Nephrology Associates Of Central FL, Orlando
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06858319A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
Mengambil pesertaFasa 2
Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07216443CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Jacksonville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.